Pfizer Director, Access Strategy, Hematology in Providence, Rhode Island
The Hematology Access Strategy Director (ASD) role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance on access, pricing, optimal reimbursement, launch sequencing, patient value, and evidence generation; she/he is responsible to develop the value and access strategy and its implementation through payer and market insights, Global and country partnerships and ensuring there is robust evidence available for the launch of hematology assets (elranatamab in multiple myeloma and a DLBCL/lymphoma pipeline compound). The Hematology ASD is also responsible for market access colleagues' development and for building a strong partnership across Global Access and Value (GAV), Global cross-functional teams and key prioritized markets.
The colleague in this role will function with a One Pfizer mindset and will lead a cross functional team of Value and Evidence (V&E) scientists, real world evidence (RWE) scientists and regional H&V/access implementation colleagues. She/he will hold cross-functional team members accountable to deliver on Access objectives. She/he will join the appropriate governance and cross-functional teams to ensure there is a single and coordinated view on strategy and delivery and will collaborate seamlessly across GAV, Global Medical, Regulatory, Commercial, Clinical, Corporate Affairs and Country Health and Value, and others. The ASD will also become a strategic partner to Global marketing, medical, and prioritized country teams.
Lead Team: Lead the cross functional Hematology (MM and DLBCL) matrix team comprised of country implementation colleagues (AI), V&E scientists, RWE scientists, regional H&V and country Access colleagues
Accountability: Holds all cross-functional team members accountable to deliver on Access strategy and objectives
Strategic Partnership: Become an active member of key governance teams and a strategic partner to Commercial, Medical, WRDM, GPD, Corporate Affairs, prioritized countries and Regulatory; effectively liaise with other functions within GAV as appropriate.
Plan & Deliver on Commitments: Orchestrate development of the integrated value and access strategy for elranatamab in 2L+ /DLBCL pipeline asset and implementation of key tactics to maximize access to patients post launch. Enable the execution of outcomes studies and projects Peri and Post launch in alignment with cross-functional colleagues to demonstrate the value proposition for hematology assets to payers and other stakeholders to ensure timely reimbursement, expanded and continued access.
External Partnerships: Develop strategic partnerships and collaborations with key external experts, healthcare policy makers, HTAs and payers, patient advocacy groups and various academic and community settings to support asset strategy.
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
Bachelor's degree minimum required / master's preferred, in a healthcare, business or economic field preferred.
Minimum 10 years' experience in health outcomes, RWD and / or market access & pricing and related fields.
In depth understanding of pricing and access dynamics is required
Experience in Hemato-oncology is preferred
Knowledge and experience in drug development. Strong technical knowledge of health economics and pricing/access
Experienced in leading a cross functional team with strong track record of high level of engagement and delivering results
Skilled in functioning within a matrix organization where managing through influence is required
Shown leadership in bringing a cross-functional to attain common goals/is able to hold team members accountable to deliver on objectives
Knowledge of the US healthcare system is preferred
Pricing negotiation experience is preferred
Strong methodological skills (study design, data analysis and interpretation) in clinical trials, epidemiology, or health services research preferred
Experience with HTA organizations such as NICE, SMC, PBAC is desirable
Experience with IDM and EM payers is a must
Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers; build strategic partnerships internally and externally
Excellent oral and written English communication skills required
Strong project management abilities (contracting, budgeting, vendor management) essential.
Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
Ability to influence key members of scientific and commercial teams constructively and without conflict
Leadership in studies that involve evidence generation, specifically related to RWE, NIS studies for access and delivering payer value
Other Job Details:
Last Date to Apply for Job: 03/27/2023
Eligible for employee referral bonus
Ability to travel internationally, up to 20%
The annual base salary for this position ranges from $156,900.00 to $261,500.00. In addition, this position offers an annual bonus with a target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program. Benefits offered include a retirement savings plan, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage in accordance with the terms and conditions of the applicable plans. Salary range does not apply to the Tampa, FL location.
Relocation assistance may be available based on business needs and/or eligibility.
Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
- Pfizer Jobs